Dapagliflozin Safe and Effective in CKD Stages 4 and 5

In a first renal outcome trial of its kind, the SGLT2 inhibitor showed favorable outcomes in the most advanced stages of CKD.
Medscape Medical News

source https://www.medscape.com/viewarticle/dapagliflozin-safe-and-effective-ckd-stages-4-and-5-2024a1000jm4?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?